Medications used for HIV Pre-Exposure Prophylaxis (PrEP) experiencing supply shortages in Australia

Blue pills.

As of 9 September 2024, Australia is currently experiencing a supply shortage of medications containing tenofovir and emtricitabine, which are commonly used for HIV Pre-Exposure Prophylaxis (PrEP). Despite this shortage, pharmacists, HIV PrEP prescribers, and people using HIV PrEP should not be alarmed — shortages are expected to resolve later this year for most brands. Current impact […]

Budget announcement marks major investment in HIV, BBVs and STIs

ASHM welcomes news from the federal budget of a $126.5 million investment over two years to support the prevention, testing and treatment of blood-borne viruses (BBVs) and STIs, alongside a $43.9 million investment to implement the recommendations of the HIV Taskforce.   This announcement represents a significant investment by the federal government in the national response […]

Preparing for PrEP in Papua New Guinea

A group of people are smiling up at the camera, holding their certificate marking the completion of their training.

Pre-Exposure Prophylaxis (PrEP) has been a game changer for HIV prevention. In Australia, biomedical HIV prevention strategies, including PrEP and treatment as prevention, have been instrumental in the significant declines in HIV transmission we have seen over the last ten years.   However, rolling out a drug regime like PrEP can be complex. And while […]

Stigma and discrimination, no place in healthcare.

Stigma and discrimination, no place in healthcare. These resources serve as a guide and support for healthcare professionals seeking to understand and address the impact of stigma and discrimination on patient care. Our materials cover best practices for creating inclusive healthcare environments, identification and mitigation of bias, and relevant research and literature on the topic. […]